Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2005
06/16/2005US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins
06/16/2005US20050130303 Stimulation of hematopoiesis by ex vivo activated immune cells
06/16/2005US20050130302 Method and composition for regulating expansion of stem cells
06/16/2005US20050130300 Method of culturing liver cells over long time
06/16/2005US20050130298 Human Embryonic Kidney (HEK293); generates appropriate level of membrane voltage, responds to potassium chloride sensitively; only T-type calcium channel activated; investigation different from traditional electrophysiological method
06/16/2005US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders
06/16/2005US20050130284 Diacylglycerol acyltransferase genes, proteins, and uses thereof
06/16/2005US20050130269 Membrane protein fusion for use as diagnostic tool in genetic engineering; reporter gene expression
06/16/2005US20050130257 Focused acoustic ejection cell sorting system and method
06/16/2005US20050130254 Apparatus comprising bioscaffold meshwork embedded with cultured liver cell for use toxicity screening tool
06/16/2005US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/16/2005US20050130209 Expression vector comprising nucleotide sequences coding deoxyribonuclease for use as tool in treatment and prevention of cystic fibrosis
06/16/2005US20050130203 Novel GABAB receptor DNA sequences
06/16/2005US20050130156 Methods for making polynucleotides and purifying double-stranded polynucleotides
06/16/2005US20050130153 Plasmid targeting vector comprising fluorescent protein for use visualization tool in confocal microscopy; automated cell sorting
06/16/2005US20050130147 Methods of preparing a targeting vector and uses thereof
06/16/2005US20050130146 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050130144 Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
06/16/2005US20050130143 Human smooth muscle myosin heavy chain polypeptide (hSMMyHC 7polypeptide) for use as tool in identifying modulator for prevention and treatment of hypertension, hypotension, heart and respiratory disorders
06/16/2005US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
06/16/2005US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design
06/16/2005US20050130127 Coronavirus-like particles comprising functionally deleted genomes
06/16/2005US20050130116 Test system comprising cells expressing polymorphic cytochrome p450 for use as drug and toxicological screening tools; bioassay; rational drug design
06/16/2005US20050129730 Tissue composites and uses thereof
06/16/2005US20050129726 Biodegradable polymer bone insert
06/16/2005US20050129720 incubating aqueous solution consisting collagen within retainers, then drying and hydrating the gels, to form hydrated and vitrified gels, used to prevent biological adhesions
06/16/2005US20050129701 Antibody to latent membrane proteins and uses thereof
06/16/2005US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants
06/16/2005US20050129674 Methods of applying a biological composition to an individual
06/16/2005US20050129673 Chondrocyte cell-lines
06/16/2005US20050129672 For isolating an enriched or purified population of motor neurons from a mixed population of human brain and/or spinal cells; for therapeutically targeting motor neurons eg myeloradiculopathy
06/16/2005US20050129671 Mammalian antigen-presenting T cells and bi-specific T cells
06/16/2005US20050129666 Compositions comprising preconditioned myoblasts having enhanced fusion properties
06/16/2005US20050129665 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
06/16/2005US20050129664 Remedy for dysmnesia
06/16/2005US20050129663 Cellular therapy; for promoting axonal regeneration in the CNS, wound healing and treatment of myocardial infarction and spinal cord injury
06/16/2005US20050129657 Interferon-alpha induced gene
06/16/2005US20050129617 Contacting a T lymphocyte from the patient with a diagnostic epitope of an amino acid string including hydrophilic amino acids and one of Leucine, Methionine, Isoleucine, Phenylalanine, Alanine, Glycine, Valine, or Tryptophan
06/16/2005US20050129614 Cancer, immune system diseases and disorders including autoimmune disease, rheumatoid arthritis, graft rejection, graft vs. host disease, and lymphadenopathy
06/16/2005CA2549158A1 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders
06/16/2005CA2548385A1 Hair growth method
06/16/2005CA2548381A1 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
06/16/2005CA2548185A1 Expression systems using mammalian .beta.-actin promoter
06/16/2005CA2547885A1 Methods for obtaining gene tags
06/16/2005CA2547787A1 Compositions comprising fetal liver cells and methods useful for hcv infection
06/16/2005CA2547668A1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
06/16/2005CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor
06/16/2005CA2547350A1 Controlling gene expression in plastids
06/16/2005CA2547233A1 Muller stem cells
06/16/2005CA2546942A1 A method for isolating a self-renewing, multipotent slow-cycling cell
06/16/2005CA2546886A1 Method for sex biasing spermatozoa
06/16/2005CA2544409A1 Use of il-6-type cytokines for maturation of oocytes
06/16/2005CA2528182A1 Antibodies specific for cancer associated antigen sm5-1 and uses thereof
06/15/2005EP1542012A1 Antibodies for detecting efavirenz
06/15/2005EP1541689A2 Hybrid proteins which form heterodimers
06/15/2005EP1541685A1 Factor participating in transcriptional regulation
06/15/2005EP1541684A1 Smg-1-binding protein and method of screening substance controlling its activity
06/15/2005EP1541681A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE WITH THE USE OF PAPILOMAVIRUS VECTOR
06/15/2005EP1541679A1 Method of analyzing organelle-localized protein and materials for analysis
06/15/2005EP1541676A1 Antibodies to fragment F1+2 of prothrombin, their production and use
06/15/2005EP1541675A2 Hybrid cells obtainable from antigen presenting cells
06/15/2005EP1541674A1 Primary cultured adipocytes for gene therapy
06/15/2005EP1541587A2 Method for down-regulating osteoprotegerin ligand activity
06/15/2005EP1541182A1 Support for tissue regeneration and process for producing the same
06/15/2005EP1541135A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof
06/15/2005EP1540349A1 Process for differential diagnosis of alzheimer s dementia i n patients exhibiting mild cognitive impairment
06/15/2005EP1540348A2 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
06/15/2005EP1540346A1 Methods and reagents for improved selection of biological materials
06/15/2005EP1540333A2 Maxs as modifiers of the axin pathway and methods of use
06/15/2005EP1540332A1 Methods of screening compounds for grk6 modulating activity
06/15/2005EP1539990A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE
06/15/2005EP1539984A2 Method for synthesis of aryl-carotenoids
06/15/2005EP1539983A2 Methods for efficient production of mammalian recombinant proteins
06/15/2005EP1539973A1 Modified adenoviral vectors for use in vaccines and gene therapy
06/15/2005EP1539972A2 Methods for inducing differentiation of embryonic stem cells and uses thereof
06/15/2005EP1539968A2 Plastid genetic engineering via somatic embryogenesis
06/15/2005EP1539964A2 Collectin-complement activating protein chimeras
06/15/2005EP1539956A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF
06/15/2005EP1539947A2 Humanized rabbit antibodies
06/15/2005EP1539944A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
06/15/2005EP1539943A2 Method for identifying mhc-presented peptide epitopes for t cells
06/15/2005EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
06/15/2005EP1539941A2 Adzymes and uses thereof
06/15/2005EP1539936A2 Cell culture surface
06/15/2005EP1539935A1 Method of separating epithelial cells from a human or animal urine sample
06/15/2005EP1539934A2 Compositions comprising muscle progenitor cells and uses thereof
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539932A1 In vitro fertilisation
06/15/2005EP1539931A1 Differentiation modulating agents and uses therefor
06/15/2005EP1539930A2 Multi-step method for the differentiation of insulin positive, glucose
06/15/2005EP1539929A2 Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
06/15/2005EP1539928A2 Cd56 positive human adult pancreatic endocrine progenitor cells
06/15/2005EP1539923A2 Bioreactor with expandable surface area for culturing cells
06/15/2005EP1539822A2 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
06/15/2005EP1539819A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
06/15/2005EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
06/15/2005EP1539809A2 Hcv fusion proteins with modified ns3 domains
06/15/2005EP1539808A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
06/15/2005EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
1 ... 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 ... 1827